| Execution period | 10 years from the date of Vesting |
|---|
NSE filing, NSE: URBANCO. Summary written from the filing by ALFA Finder's alert engine.
Urban Company Ltd: key numbers
- Share price
- ₹144.68
- Market cap
- ₹22,312 Cr
- Revenue (annual)
- ₹1,556 Cr
- Net profit (annual)
- ₹-234.8 Cr
- P/E (TTM)
- -48.8×Sector 34.1×
- Promoter holding
- 19.02%+0.00% QoQ
- FII holding
- 52.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Urban Company Ltd
All →Urban Company Earnings Call Transcript: Key Takeaways
Urban Company reported a sharp 41.4% revenue jump, yet management's pivot to a ₹2,500 Cr capital raise despite a strong cash balance suggests aggressive M&A or high-stakes competitive defense in InstaHelp.
Urban Company Annual General Meeting
Urban Company has issued a postal ballot notice to seek shareholder approval for raising up to ₹2,500 crore through an issuance of securities.
Urban Company Fund Raise of ₹2,500 Cr
Urban Company's board approved a fresh capital raise of up to ₹2,500 Cr. Additionally, Q2 FY27 revenue grew 41% YoY to ₹537 Cr.
- Value
- ₹2,500 Cr
Urban Company Business Update
Urban Company released its Q2 FY27 Shareholders' Letter, reporting strong growth momentum across core segments and announcing board approval to raise capital up to ₹2,500 Crore.
- Value
- ₹2,500 Cr
Urban Company Q2 FY27 Results: Net Loss of ₹182.5 Cr, Loss Widens
Urban Company Ltd reported revenue from operations of ₹537.3 Cr (+41.4% YoY) and a net loss of ₹182.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹182.5 Cr
Urban Company Other Announcement
Urban Company Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date